Bid by 23andme’s Former CEO to Buy Company Given Greenlight by Court – National | Globalnews.ca

Anne Wojcicki’s bid to buy 23andme, the genetic testing company She Cofounded Nearly 20 years ago, has received the court greenlight.

That means wojcicki’s nonprofit ttam research institute The transaction – which Arrives more than three months after 23andme filed for chapter 11 bankruptcy – is set to official close in the coming weeks.

“I am thrilled that ttam will be able to build on the mission of 23and to help people access, understand and benefit from the human genome,” Wojcicki said in a statement mode ” Care Belongs to all of us. “

The sale, which was approved by us bankruptcy judge brian c. walsh on Friday, marks the end of a month of a month of a month of a month of a month of a month of a month of a month of a month Previous agreed to buy Most of 23andme’s assets for us $ 256 million in May. But Wojcicki’s Nonprofit Later Topped That Offer, Winning the Final Round of Bidding Held Last Month.

Story Continues Below Advertisement

Under the deal, Ttam will Acquire 23and’s Signature “Personal Genome Service” Provided through the company’s saliva-spoiled DNA testing kits-As Well as Research Operations and Its lemonida Subsidiya, a Telehealth Services Provider that 23andme Previously planned to wind down.

WojCicki had worked to take 23andme private for some time. With the company struggling to find a profitable business model since going public in 2021, She’s maintained that it would operate better outside market pressures. But that endeavor proved to be tumulture – notable in September of last year, when all of 23and’s indecent directors resigned from its board citing a “clea The company’s future following drawn-out negotiations.

Get the Day's Top News, Political, Economic, and Current Affairs Headlines, delivered to your inbox on a day.

Get Daily National News

Table of Contents

Get the Day’s Top News, Political, Economic, and Current Affairs Headlines, delivered to your inbox on a day.

Leading up to 23andme’s march bankruptcy filing, subsequent efforts from wojcicki to acquire the company was unsuccessful. And when 23andme filed for chapter 11 in late March, Wojcicki Resigned as Ceo – Noting at the time that she was stepping down to be “in the best position” in the best position ”.


Click to Play Video: '23andme Lacked Strong Data Protection Allowing for Breach: Canada's Privacy Head'


23andme Lacked Strong Data Protection Allowing for Breach: Canada’s Privacy Head


Now that Wojcicki’s Nonprofit Will Acquire 23andme, IT’s Unclear Whether the Co-Founder Will Step Back into the CEO SEAT. But despite stepping down from the top post months ago, wojcicki has reminded on the company’s board throughout the bankruptcy process.

Story Continues Below Advertisement

Beyond Financial Strains Leading Up to 23andme’s Bankruptcy, Privacy Concerns Related to Customers’ Genetic Information also Emerged – Dating Back to Eveen Before The Bankruptcy Processes Data Breach. But Concern What New Owneship Cold Mean for 23andme users’ Personal data has bubbled up in recent months. The genetic testing business had about 13 million customers at the time of its salarying, court documents note.

In June, 27 States and the District of Columbia Filed a Lawsuit Seeking to Block the Sale of Personal Genetic Data by 23andme without Customer Consent. And in a Memorandum Opinion Outlining His Approval 23andme’s Sale to Ttam on Friday, WALSH ACKNOWLEDGED these states’ objections to the acquisition – but that noted many has been done. Still, California, KentTocky, Tennesee, Texas, and Utah “Remain actively opposed to the sale.”


In a statement to politico on Monday, California Attorney General Rob Bonta’s Office Maintened that 23andme’s Sale ”Does Not Comply” With Genetic Privacy Law in the state – And Said It Was “disapointed” With the court’s approval, adding that it was evaluating next steps.

The associateed press reached out to Bonta’s Office and 23andme for Further Comments on Tuesday.

When Announcing its intended sale to wojcicki’s nonprofit last month, 23andme confirmed that ttam “has affected its committee” to comply with the company policy. That means ttam will honor existing policies Around Consumer Data, The Company Said, Which Includes Allowing Users to delete their data and “opt out” of research.

Story Continues Below Advertisement

All customers will be emailed at least two business days before the acquisition closes – with details on ttam’s privacy commitments and instructions on how to delete data or opt out of Research, 23 Said. The company added that ttam will offer customers two years of Experian Identity Theft monitoring at no cost.

23andme reiterated thats privacy policies on Monday. And wojcicki added that, “core to my beliefs is that individuals should be Empowered to have choice and transparency with respect to their genetic data and have the opptunity to content to content Ancestry and Health Risks as They Wish. “

& Copy 2025 The Canadian Press

Ramesh Ghorai is the founder of www.livenewsblogger.com, a platform dedicated to delivering exclusive live news from across the globe and the local market. With a passion for covering diverse topics, he ensures readers stay updated with the latest and most reliable information. Over the past two years, Ramesh has also specialized in writing top software reviews, partnering with various software companies to provide in-depth insights and unbiased evaluations. His mission is to combine news reporting with valuable technology reviews, helping readers stay informed and make smarter choices.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top